Form 4 for AORT ARTIVION, INC.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0000784199-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-04 | 2024-01-02 | AORT | Holloway Jean F | SVP, GC | M - OptEx | $16.30 | +21.2K | 154.7K | +16% | +$346.0K |
| D | 2024-01-04 | 2024-01-02 | AORT | Holloway Jean F | SVP, GC | S - Sale+OE | $18.00 | -21.2K | 133.5K | -14% | -$382.1K |
| D | 2024-01-04 | 2024-01-02 | AORT | Holloway Jean F | SVP, GC | M - OptEx | $16.30 | -21.2K | 0 | -100% | -$346.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | M | A | 21,229 | $16.30 | 154,749 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. |
| 2 | Common | Common Stock | 2024-01-02 | S | D | 21,229 | $18.00 | 133,520 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. (F2) Reflects the price the shares were sold. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-01-02 | M | D | 21,229 | $16.30 | 0 | D | $16.30 · 2018-02-21 to 2024-02-21 | 21,229 Common Stock | (F3) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. |